Reports say scientists are working on the formulation of a new drug that may slow down diseases like Parkinson's, Alzheimer's and Huntington's.
Professor Hagit Eldar-Finkelman of Tel Aviv University's Sackler School of Medicine and colleagues teamed up with chemists, biotechnologists and 3-D modelists to "build" the new drug, L803-MTS.
Scientists May Have The Answer To Parkinsons
Parkinson's disease is a progressive disorder that often deteriorates movement.
Parkinson's disease is a progressive disorder that often deteriorates movement.
Prof. Eldar-Finkelman said: "Ours is the first lab that showed the importance of GSK3 as a target in Type II diabetes, and was among the first to introduce a specific inhibitor against the GSK3.
"Our approach became so popular that today many pharmaceutical companies, big and small, are competing to work on a GSK3 inhibitor."
Diabetes Increases Alzheimer's Risk: Study
Research has shown that diabetes increases the risk of Alzheimer''s disease and the risk of memory loss in people who don''t have Alzheimer''s disease.
Research has shown that diabetes increases the risk of Alzheimer''s disease and the risk of memory loss in people who don''t have Alzheimer''s disease.
Recent research findings on the L803-MTS drug have been published in the Journal of Molecular Biology (2008) and Current Pharmaceutical Design (2009).
Advertisement
Gene Mutation Linked to Huntington's Disease
Scientists at the University of Illinois at Chicago College of Medicine have found out how a mutated gene acts on the nervous system to create the devastation of Huntington's disease.
Scientists at the University of Illinois at Chicago College of Medicine have found out how a mutated gene acts on the nervous system to create the devastation of Huntington's disease.
ARU
